Trial Profile
Phase III, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU)in Hypogonadal Men
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Testosterone undecanoate (Primary)
- Indications Hormone deficiency; Hypogonadism
- Focus Registrational; Therapeutic Use
- 25 Jan 2013 New trial record
- 01 Jan 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.